z-logo
open-access-imgOpen Access
In Vivo Development of Ertapenem Resistance in a Patient with Pneumonia Caused by Klebsiella pneumoniae with an Extended-Spectrum -Lactamase
Author(s) -
Eugenne Elliott,
Adrian Brink,
Johan van Greune,
Z. Els,
Neil Woodford,
Jane F. Turton,
Morgyn S. Warner,
D. M. Livermore
Publication year - 2006
Publication title -
clinical infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.44
H-Index - 336
eISSN - 1537-6591
pISSN - 1058-4838
DOI - 10.1086/503264
Subject(s) - ertapenem , klebsiella pneumoniae , microbiology and biotechnology , klebsiella pneumonia , in vivo , medicine , pneumonia , porin , beta lactamase , enterobacteriaceae , antibiotics , antibiotic resistance , imipenem , bacteria , biology , pseudomonas aeruginosa , escherichia coli , bacterial outer membrane , gene , biochemistry , genetics
Four sequential extended-spectrum beta -lactamase-producing isolates of Klebsiella pneumoniae were obtained from a patient after treatment with ertapenem and cultured. The first and fourth isolates were susceptible to ertapenem, whereas the second and third were resistant. All 4 isolates belonged to the same strain and produced a group 1 CTX-M enzyme; additionally, the resistant isolates had lost a porin.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom